Biotech-drugs to drive India’s cold chain supply market

In the next couple of years, the major driver for cold chain supply market will be the development, production and manufacturing of drugs led by the biotechnology industry

x

(Photo Courtesy: www.nccd.gov.in)

The Industry

India's integrated cold chain industry is composed of a combination of surface storage and refrigerated transport, growing at a CAGR of ~20 percent in the last three years.

The Indian cold chain market is estimated to be worth $8 billion and is expected to touch $13 billion by 2018. Out of the $8 billion, less than $2 billion is shared by the biotech and pharmaceutical industry.

Currently India roughly has about 6,300 cold storage facilities. Under the 12th Five Year Plan (2012-2017), the Department of Pharmaceuticals has asked for the assistance worth Rs 50 crore ($9.2 million) for setting up cold chain facilities across India.

The Trends

 

Previous 1 3 4 5 6 7 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X